Erlotinib Resistance in Lung Cancer Cells Mediated by Integrin β1/Src/Akt-Driven Bypass Signaling

Rina Kanda, Akihiko Kawahara, Kosuke Watari, +9

Cancer Research

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor

Koichi Azuma, Akihiko Kawahara, Kahori Sonoda, +8

Oncotarget

Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells

Keisuke Tabara, Rina Kanda, Kahori Sonoda, +14

PLoS ONE

Sorting nexin 2‐mediated membrane trafficking of c‐<scp>M</scp>et contributes to sensitivity of molecular‐targeted drugs

Sayaka Ogi, Hideaki Fujita, Masaki Kashihara, +8

Cancer Science

The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutated<i>EGFR</i>gene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cells

Yûichi Murakami, Kahori Sonoda, Hideyuki Abe, +11

Oncotarget